Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan J Battermann

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2010
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcomeKarel A Hinnen, Marinus A Moerland, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2010
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancerEllen M A Roeloffzen, Irene M Lips, Marion P R van Gellekom, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Cataract after total body irradiation and bone marrow transplantation: degree of visual impairmentM Loes van Kempen-Harteveld, Henk Struikmans, Henk B Kal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 7, 2010
[Guideline on urothelial carcinoma of the bladder]Rob F M Bevers, Jan J Battermann, Jourik A Gietema, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2009
Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrencesMaaike R Moman, Cornelis A T van den Berg, Arto E Boeken Kruger, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma--a feasibility studyMarco van Vulpen, Bas W Raaymakers, Jan J W Lagendijk, et al.
World Journal of Urology|August 21, 2012
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature reviewMax Peters, Maaike R Moman, Henk G van der Poel, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 11, 2010
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcomeKarel A Hinnen, Marinus A Moerland, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2010
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancerEllen M A Roeloffzen, Irene M Lips, Marion P R van Gellekom, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Cataract after total body irradiation and bone marrow transplantation: degree of visual impairmentM Loes van Kempen-Harteveld, Henk Struikmans, Henk B Kal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Prostate brachytherapy and second primary cancer risk: a competitive risk analysisKarel A Hinnen, Michael Schaapveld, Marco van Vulpen, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 7, 2010
[Guideline on urothelial carcinoma of the bladder]Rob F M Bevers, Jan J Battermann, Jourik A Gietema, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2009
Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrencesMaaike R Moman, Cornelis A T van den Berg, Arto E Boeken Kruger, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma--a feasibility studyMarco van Vulpen, Bas W Raaymakers, Jan J W Lagendijk, et al.
World Journal of Urology|August 21, 2012
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature reviewMax Peters, Maaike R Moman, Henk G van der Poel, et al.
Pageof 4